CN109602704A — 丁酸氯维地平脂肪乳注射液及其制备工艺
Assigned to GUANGDONG JIABO PHARMACEUTICAL Co Ltd · Expires 2019-04-12 · 7y expired
What this patent protects
本发明提供一种丁酸氯维地平脂肪乳注射液的处方及其制备工艺。所述的丁酸氯维地平脂肪乳注射液的处方包括:丁酸氯维地平,注射用油,有机溶剂,乳化剂,助乳剂,等渗调节剂,稳定剂,pH调节剂和注射用水。该处方及工艺可提高丁酸氯维地平溶解性和包封率,降低因贮存温度发生变化而引起的脂肪乳破乳、分层的风险,减少药品贮存过程中丁酸氯维地平的降解,最终得到稳定性更好,安全性更高的产品。
USPTO Abstract
本发明提供一种丁酸氯维地平脂肪乳注射液的处方及其制备工艺。所述的丁酸氯维地平脂肪乳注射液的处方包括:丁酸氯维地平,注射用油,有机溶剂,乳化剂,助乳剂,等渗调节剂,稳定剂,pH调节剂和注射用水。该处方及工艺可提高丁酸氯维地平溶解性和包封率,降低因贮存温度发生变化而引起的脂肪乳破乳、分层的风险,减少药品贮存过程中丁酸氯维地平的降解,最终得到稳定性更好,安全性更高的产品。
Drugs covered by this patent
- Cleviprex (CLEVIDIPINE) · Chiesi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.